News &amp; Updates

Cancer patients receiving either low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) show comparable frequency of venous thromboembolism (VTE), reports a recent study.

19 Oct 2021

Marine omega-3 supplementation may promote atrial fibrillation

Supplementation with marine omega-3 fatty acids appears to contribute to an increased risk of atrial fibrillation (AF), especially at higher doses, according to the results of a meta-analysis.

Tezepelumab improves lung function in severe asthma

In the treatment of patients with severe, uncontrolled asthma, use of tezepelumab appears to produce rapid and sustained improvements in lung function, as reported in a study.

19 Oct 2021

Ozanimod effective as induction, maintenance therapy for ulcerative colitis

A once-daily oral formulation of ozanimod, a selective sphingosine-1-phosphate (S1P) receptor modulator, outdid placebo as induction and maintenance therapy for moderate-to-severe* active ulcerative colitis (UC), findings from the phase III True North study have shown.

3-day remdesivir prevents hospitalization, death in COVID-19

A 3-day course of remdesivir may help stave off COVID-19–related hospitalization and death, according to results of the phase III PINETREE study.

18 Oct 2021

Drug-delivery device implant works well for neovascular AMD

An ocular implant that continuously dispenses an antivascular endothelial growth factor (anti-VEGF) therapy into the vitreous performs well in the management of neovascular age-related macular degeneration, affording disease control and achieving vision and anatomical outcomes similar to that obtained with monthly intravitreal injections, as shown in the phase III ARCHWAY trial.

18 Oct 2021

Warfarin plus aspirin tied to higher bleeding risk than monotherapy in AF patients

The combination of aspirin and warfarin therapy appears to increase the risk of bleeding, with little benefit in reducing stroke or cardiovascular events compared with warfarin alone in patients with atrial fibrillation (AF), reveals a study.

18 Oct 2021

Antiplatelet plus anticoagulant therapy linked to better outcomes in COVID-19

Hospitalized patients with COVID-19 who receive antiplatelet and anticoagulant drugs concurrently may fare better than those given only therapeutic anticoagulation, according to a study.

18 Oct 2021

Tapinarof a new kid on the block for plaque psoriasis

Treatment with the nonsteroidal topical cream tapinarof 1% for up to 52 weeks helps control plaque psoriasis in the phase III PSOARING 3 trial.